Posted by AGORACOM
at 10:23 AM on Wednesday, September 23rd, 2020
Tartisan Nickel Corp. owns the Kenbridge Nickel Project in northwestern Ontario, the Sill Lake Silver Property in Sault St. Marie, Ontario as well as the Don Pancho Manganese-Zinc-Lead-Silver Project in Peru. The Company has an equity stake in; Eloro Resources Limited, Class 1 Nickel & Technologies Limited and Peruvian Metals Corp. Click Here For More Info
Calling traditional metal refining processes “legacy” and “insanely complicated”, Elon Musk said today his company has re-thought and simplified how lithium and nickel will be processed for his future batteries.
Musk made the comments during a live simulcast presentation of Battery Day held in a parking lot in Fremont, California, near his manufacturing facilities. Musk shared part of the presentation with Drew Baglino, SVP of Powertrain and Energy Engineering at Tesla.
Musk called the traditional cathode process of processing nickel “a big target” due to its high cost
“It’s insanely complicated,” said Musk. “These things just grow up as legacy. We looked at the entire value chain and asked how can we make this as simple as possible.”
Bagnilo and Musk said many steps in the traditional refining method could be skipped resulting in 66% less investment, 76% less processing cost and 0% waste water.
The CEO of FPX Nickel, Martin Turenne, concurred with Musk: mineral processing can be made cleaner and more economical.
“The current methods of processing [nickel] are generally well established, and they’re done for a reason, because they work and because alternatives would be costly or they’re at an unproven stage,” said Turenne in an interview with Kitco after he watched Tesla’s Battery Day presentation.
At his own FPX, Turenne believes his nickel is in a form that would be suitable for batteries with the potential to skip the smelting step.
Musk and Bragnila imagine Tesla factories processing raw nickel powder for processing.
“Raw materials from a mine go to the plant and out comes a battery,” said Bragnila. “We are just consuming the raw nickel powder. It dramalitcally simplifies the raw nickel refining part of the whole process. We can eliminate billions in battery grade nickel intermediate production. It is not needed at all.”
What struck Turenne during the presentation is the forecast level of demand.
“At three terawatt-hours of battery cells per annum by 2030, that would entail approximately annual consumption of 2 million tonnes of nickel. That’s almost the entire scale of the current global nickel output,” said Turenne.
“Our team at Kontrol has been very busy since the completion of pre-commercialization testing through the independent labs,” says Paul Ghezzi, CEO of Kontrol. “We have now moved to the commercialization phase for the Kontrol BioCloud® analyzer (“BioCloud analyzer” or “BioCloud”) which includes further lab testing to establish the lower detection limits. In addition, we are pleased to share that BioCloud is receiving interest from potential customers and distribution partners and we are selecting key suppliers for commercialization. We are in discussions with provincial and federal government entities regarding contributions to commercialization funding and potential future procurement. Our internal goal is to have BioCloud units commercially available in November 2020.”
Commercialization of BioCloud
As part of BioCloud’s commercialization plans, Kontrol will provide lower detection limits and operating specifications for the analyzer. Initial expectations, based on lab testing completed to date, is that BioCloud will be effective in small to medium space settings with 3 or more people, and therefore would be suitable for applications in many environments such as classrooms, offices, airplanes, trains, buses, long-term care facilities and hospitals.
Like all electrical products, BioCloud is required to operate with a CSA approval in Canada. The Company is in the process of seeking CSA approvals as part of commercialization. CSA is a leader in Standards Development and in Testing, Inspection and Certification around the world including Canada, the U.S., Europe and Asia. The CSA registered mark shows that a product has been independently tested and certified to meet recognized standards for safety or performance. The Company has a long history of success in achieving CSA approvals in our established continuous emissions business.
Operating Subsidiaries, Trademarks and Patents
Kontrol BioCloud Inc., which was recently incorporated, is a wholly owned subsidiary of Kontrol, and will be the primary sales and marketing entity for BioCloud. CEM Specialties Inc. (“CEMSI”), also a wholly owned operating subsidiary of Kontrol, will be the primary research, development, and integration entity for BioCloud.
Kontrol has commenced the trademark of the term Safe Space Technology and has initiated the patent registration for its intellectual property related to BioCloud.
Securing Supply Chain
Kontrol has selected a number of suppliers that will form part of BioCloud supply chain, and we will be announcing those names in the coming weeks, following the issuance of applicable purchase orders.
“While we are not making any claims about revenue at this time, we are building our global supply chain with the goal of being able to supply the market with up to 20,000 units per month,” says Gary Saunders VP of Kontrol. “We plan to have this substantially completed over the coming weeks.”
Strengthened Balance Sheet and Discussions for Additional Government Funding
As of September 22, 2020, the Company has received approximately $1 Million in cash from the exercise of common share options and warrants which has strengthened Kontrol’s balance sheet to advance BioCloud’s commercialization.
About Kontrol BioCloud
BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality continuously. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, retirement homes, hospitals, mass transportation and others. It can be an important technology which supports the entire system of individual testing and contact tracing.
The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).
About Kontrol Energy
Kontrol Energy Corp. (CSE:KNR) (OTCQB:KNRLF) (FSE:1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.
Kontrol Energy is one of Canada’s fastest growing companies in 2018 and 2019 as ranked by Canadian Business and Maclean’s.
Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com.
For further information, contact:
Paul Ghezzi, Chief Executive Officer [email protected] or [email protected] Kontrol Energy Corp., 180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8 Tel: 905.766.0400, Toll free: 1.844.566.8123
Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.
However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.
Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.
Posted by AGORACOM
at 8:10 AM on Tuesday, September 22nd, 2020
Tartisan Nickel Corp. owns the Kenbridge Nickel Project in northwestern Ontario, the Sill Lake Silver Property in Sault St. Marie, Ontario as well as the Don Pancho Manganese-Zinc-Lead-Silver Project in Peru. The Company has an equity stake in; Eloro Resources Limited, Class 1 Nickel & Technologies Limited and Peruvian Metals Corp.
The federal government is planning investments in the electric vehicle industry to create a domestic supply chain for electric vehicle batteries that could supply the North American market. (Jonathan Hayward/The Canadian Press)
The Liberal government will use the speech from the throne to lay out a plan to create tens of thousands of jobs by connecting Canada’s resource sector with its manufacturing base to produce batteries for electric cars, Radio-Canada has learned.
“We recognize we have a unique opportunity to take advantage of our skilled labour force and we know we have a long and proud history of manufacturing vehicles, planes, ships and trains, and we also have an abundant amount of natural resources,” Innovation, Science and Industry Minister Navdeep Bains told Radio-Canada.
“We could be a world leader in [electric vehicle] battery manufacturing if we leverage our natural resources like lithium, cobalt … nickel, aluminum — the key ingredients that are required in batteries. Then we want to make sure that we manufacture them here and … use them in our trains, our buses, our ships and our planes.”
Bains said the green technology sector is expected to be worth trillions of dollars in the coming years and Canada could take advantage of that market by positioning itself as the chief North American supplier of batteries for electric vehicles.
“Not only do we want to be in a position to be building [electric vehicle] batteries here in Canada for the North American market, we want to be a global leader to take advantage of global opportunities,” he said.
CBC News has confirmed a report which first appeared in the Toronto Star — that the federal government is willing to put up to $500 million, with some money coming from the Ontario government, toward turning Ford’s Oakville plant over to the production of electric vehicles, an investment that could keep the plant open for years to come.
The paper reported that the mass production of electric vehicles and batteries is at the heart of talks between Ford Motor Co. and the union representing its employees.
When asked about the deal yesterday Ontario Premier Doug Ford said negotiations are still ongoing.
“What I can tell you is how important the auto industry is, one of the most important industries in Ontario,” he said during his daily briefing.
“This is good if we move forward. The parts are very important. We would like to manufacture the batteries here rather than bringing the batteries in from out of country. We have the capabilities and the raw materials here. Why can’t we produce the batteries? That’s my big ask to Ford.”
Adding value through manufacturing
Bains also said his government is looking at putting money into high-speed internet access — something he said the country needs more of now, with more and more Canadians working from home.
He also said the federal government is looking at investments in the agriculture sector to help make Canada “a world leader in plant proteins.”
Bains did not say if the agriculture and internet proposals will be a part of the throne speech.
“The bottom line is that we want to take advantage of what we have in Canada,” he said. “And what we have is an incredibly skilled labour workforce, we have natural resources and we have the ability to add value through our manufacturing processing initiatives.”
Posted by AGORACOM-JC
at 7:09 AM on Tuesday, September 22nd, 2020
ImagineAR CEO Alen Paul Silverrstieen will be presenting at Wall Street Reporter’s “Next Super Stock” livestream conference on September 24, 2020 at 12:30pm EDT .
VANCOUVER , BC AND ERIE, PA , Sept. 22, 2020 – Imagine AR Inc . (CSE: IP), (OTCQB: IPNFF), the ONLY Self-Service Augmented Reality Mobile Platform for sports teams and businesses to instantly create immersive campaigns around the world is excited to announce that ImagineAR CEO Alen Paul Silverrstieen will be presenting at Wall Street Reporter’s “Next Super Stock” livestream conference on September 24, 2020 at 12:30pm EDT .
For those unable to join the live event, a video of the presentation will be posted later.
About “Next Super Stock Live!” conference:
Wall Street Reporter’s “NEXT SUPER STOCK Live!” The conference is dedicated to featuring select companies that have near-term catalysts in place which can drive transformational growth (and stock appreciation) in the months ahead.
About ImagineAR
ImagineAR Inc. (CSE: IP) (OTC: IPNFF) is an augmented reality (AR) platform, ImagineAR.com, that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, (products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies. The AR Platform is available as an SDK Plug-in for existing mobile apps.
This News Release is available on the company’s CEO Verified Discussion Forum , a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.
We encourage you to do your own due diligence and ask your broker if Imagination Park Entertainment Inc. (cse: IP) is suitable for your particular investment portfolio*.
The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release. This press release may include ‘forward-looking information’ within the meaning of Canadian securities legislation, concerning the business of the Company. The forward looking information is based on certain key expectations and assumptions made by ImagineAR management. Although ImagineAR believes that the expectations and assumptions on which such forward- looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because ImagineAR can give no assurance that it will prove to be correct. These forward-looking statements are made as of the date of this press release, and ImagineAR disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
Posted by AGORACOM
at 10:04 AM on Monday, September 21st, 2020
Toronto, Ontario–(Newsfile Corp. – September 21, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has granted a prominent Canadian production company and film crew exclusive access to provide video coverage of the activities of the Company and its Chief Executive Officer, Todd Shapiro, within the Netherlands, leading up to the Company’s previously announced iMicrodose product launch party (the “iMicrodoseLaunch Party“), scheduled on September 25, 2020, in Amsterdam, the Netherlands. Filming commenced on September 20, 2020 in Horst, the Netherlands (the location of the Company’s production and distribution facility) and will continue through to the iMicrodose Launch Party, covering, among other things, the iMicrodose brand, and the production and distribution facility.
“I’m so grateful for this production company reaching out and offering to document our journey. There’s a ton of hard work that is going on behind the scenes and if all goes according to plan – this will be another piece of earned Media, which hasn’t cost Red Light Holland a dime, to potentially highlight our Company, our tireless efforts and our iMicrodose brand to a much bigger widespread audience,” said Chief Executive Officer and Director of the Company, Todd Shapiro. “Out of respect to the production company’s intellectual property rights, which play a huge role in stimulating innovation and creativity – in this case focusing on Red Light Holland’s early magic truffles production facility, our iMicrodose product launch in the Netherlands, and our expected iMicrodose Launch Party – we’ve mutually agreed to hold off on providing more information for now. However, we look forward to sharing more details in early 2021 about this great exposure opportunity… Now let’s just hope my mug doesn’t get left on the cutting room floor!”
About Red Light Holland Corp.
The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.
Posted by AGORACOM-JC
at 9:57 AM on Monday, September 21st, 2020
SPONSOR: Red Light Holland (CSE: TRIP) is engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands. Learn more.
Can magic mushrooms treat depression? Biotech COMPASS Pathways prices upsized US IPO above the range at $17
Raised $128 million by offering 7.5 million ADSs at $17, above the range of $14 to $16
The company offered 0.8 million more ADSs than anticipated
At pricing, the company raised 27% more in proceeds than expected
Contributor: Renaissance Capital
COMPASS Pathways, a British Phase 2 biotech developing a psilocybin-based therapy for depression, raised $128 million by offering 7.5 million ADSs at $17, above the range of $14 to $16. The company offered 0.8 million more ADSs than anticipated. At pricing, the company raised 27% more in proceeds than expected.
COMPASS Pathways plans to list on the Nasdaq under the symbol CMPS. Cowen, Evercore ISI and Berenberg acted as lead managers on the deal.
The company is focusing on using its proprietary formulation of psilocybin, COMP360, in conjunction with psychological support as a way to help individuals who have treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD. COMPASS is currently evaluating COMP360 in conjunction with psychological support in a Phase 2b trial and plans to report data from this trial in late 2021. Classified as a Schedule I drug, psilocybin is considered a serotonergic hallucinogen and is an active ingredient in some species of mushrooms.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital’s research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital’s Renaissance IPO ETF (symbol: IPO), Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of companies mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Posted by AGORACOM-JC
at 9:32 AM on Monday, September 21st, 2020
Company has launched its new domain www.PlantX.ca to better serve the Canadian market
New .ca domain will allow PlantX, the one-stop-shop for everything plant-based and the digital face of the plant-based community, to strengthen its Canadian presence and ability to offer its growing plant-based product line to Canadian consumers using its e-commerce platform
VANCOUVER, BC, Sept. 21, 2020 – Vegaste Technologies Corp. (the ” Company ” or ” Vegaste “) (CSE: VEGA ), is pleased to announce that the Company has launched its new domain www.PlantX.ca to better serve the Canadian market.
The new .ca domain will allow PlantX, the one-stop-shop for everything plant-based and the digital face of the plant-based community, to strengthen its Canadian presence and ability to offer its growing plant-based product line to Canadian consumers using its e-commerce platform.
The new domain www.PlantX.ca will feature a growing list of partnerships with Canadian companies including Vita Life Fresh Market and UpMeals to offer plant-based vitamins, supplements, groceries, PlantX-branded water and plant-based meals made by LA-based chef Gregg Drusinsky . In addition to its e-commerce functionality, the site will offer Canadian consumers weekly updated plant-based recipes, restaurant resources and connects like-minded users in a community forum.
“Having a “.ca” domain is very exciting for us as a Canadian-based company,” said Sean Dollinger , PlantX founder “We plan to use this as an example of what we can do around the world as we expand, continue making new partnerships, and offer the best products and experience in every market.”
“At PlantX we’ve built our online platform with a different set of inventory, shipping logistics, payment processors, and other logistics separated by region,” says Alexandra Hoffman , PlantX Chief Marketing Officer. “Dividing the company traffic among different domains makes the company’s regional logistics systems better. I work very close with our development team, and it’s so exciting to see how quickly we can deploy sites for new locations.”
Since its inception in October, 2019, the Company’s PlantX platform has quickly emerged as an industry leader. As the fledgling plant-based sector continues its explosive growth, the Company will be at the forefront by continually evolving and delivering new ways to expand PlantX. With its forward-looking, cutting edge approach, the Company will continue to secure significant partnerships across North America while exploring innovative ways to expand both its e-commerce capabilities and digital resources to help educate, inspire, and uplift consumers.
About Vegaste
As the digital face of the plant-based community, Vegaste’s PlantX platform is the one-stop-shop for everything plant-based. With its fast growing category verticals, the Company will offer customers across North America more than 10,000 plant-based products by the end of September. In addition to offering meal and indoor plant deliveries, Vegaste currently has plans underway to expand its product lines to include cosmetics, vitamins, clothing, and its own water brand — but the business is not limited to an e-commerce platform. Vegaste uses its digital platform to build a community of like-minded consumers and most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs, and brands. Vegaste eliminates the barriers to entry for anyone interested in living a plant-based lifestyle, and thriving in a longer, healthier, and happier life.
The Company’s lynchpin www.PlantX.com is the digital face of everything plant-based and fueled by the power of education and accessibility. For those who don’t have the time to cook their own healthy plant-based meals, Vegaste offers a wide array of pre-made meals curated by Executive Chefs and nutritionists. For those looking to learn how to cook their own plant-based meals, Vegaste offers regularly updated weekly recipes. Unlike other plant-based e-commerce companies, Vegaste has a large selection of indoor plants for sale. The site educates consumers on the benefits of a plant-based diet with a specialized blog, connects like-minded individuals with its forum, and provides resources for the best plant-based restaurants, pop-up retailers and products across Canada and the USA .
Forward-Looking Information
This press release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. The forward-looking information contained herein includes statements regarding the business and strategic plans of the Company.
By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release including, without limitation: the Company’s ability to secure additional commercial partnerships across North America , the Company’s ability to comply with all applicable governmental regulations including all applicable food safety laws and regulations; impacts to the business and operations of the Company due to the COVID-19 epidemic; a limited operating history, the ability of the Company to access capital to meet future financing needs; the Company’s reliance on management and key personnel; competition; changes in consumer trends; foreign currency fluctuations; and general economic, market or business conditions.
Additional risk factors can also be found in the Company’s continuous disclosure documents which have been filed on SEDAR and can be accessed at www.sedar.com . Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.
The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Posted by AGORACOM-JC
at 9:27 AM on Monday, September 21st, 2020
Avicanna Rapid Act Spray
RHO Phyto™ Rapid Act Sprays are now available nationwide in high ratios of CBD to THC and are designed for rapid absorption and with lemon-mint flavour on the Medical Cannabis by Shoppers™ portal.
The Rapid Act Sprays are also available for the Medical Cannabis Real World Evidence Studies (MC-RWE) conducted by the University Health Network in partnerships with Medical Cannabis by Shoppers along side RHO Phyto’s Micro Drop Oil formulations.
TORONTO , Sept. 21, 2020 – Avicanna Inc. (” Avicanna ” or the ” Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that its advanced RHO Phyto Rapid Act Sprays are now officially available nationwide in Canada on the Medical Cannabis by Shoppers (” Shoppers “) portal, as well as through the Medical Cannabis Real-World Evidence Study at the University Health Network.
Avicanna’s RHO Phyto product line is now commercially available after years of research and development through collaborations with world class academic and clinical organizations. The development of RHO Phyto products has focused on the key properties in drug development that health care providers seek when recommending a medical product to their patients such as formulation stability for consistent dosing, enhanced absorption and a range of onset times.
The Rapid Act Spray is a sublingual spray and is among the second set of Avicanna’s RHO Phyto products available for purchase through Shoppers. The sublingual sprays bypass first-pass metabolism and are quickly absorbed in the mucosal lining under the tongue. The RHO Phyto Rapid Act Spray provides an alternative delivery form to the RHO Phyto Micro Drops (also available for sale through Shoppers) which are absorbed through the oral route. The RHO Phyto Rapid Act Sprays have been formulated with specific ingredients that enhance absorption and the onset time of cannabinoids across the mucous membrane beneath the tongue. The lemon-mint flavoured sprays will be available in 10:20 CBD and 2:40 (w/w) THC to CBD ratios.
Dr. Justin Grant , Avicanna’s Executive Vice President of Scientific Affairs, commented, “The RHO Phyto Rapid Act Sprays are designed for faster onset and can be used in acute conditions where patients seek faster relief. The sublingual sprays can also be used to supplement slower and longer acting products, such as the RHO Phyto Micro Drop, when occasional higher doses may be required. Sublingual administration provides an alternative to the potentially harmful effects of consuming inhalation products.”
In August 2020 , Avicanna launched its blood orange flavoured RHO Phyto Micro Drop 2:50 CBD and Micro Drop 5:20 CBD. In the coming months, Avicanna will be launching its much-anticipated RHO Phyto Deep Tissue Gel, Daily Cream and Simple Dose Capsules. To ensure batch-to-batch consistency and high-quality products, these formulations are manufactured at MediPharm Labs Inc, a Good Manufacturing Practices (” GMP “) certified facility. In addition to strict GMP manufacturing, all RHO Phyto products undergo GMP-level analytical testing by Sigma Analytical Services Inc. and use blockchain technology developed by TruTrace Technologies Inc. to manage, track and trace each step of the supply chain.
Detailed guidelines outlining dosing and titration for Health Care Practitioners (” HCPs “) and patients is available on the RHO Phyto website at www.rhophyto.com . In addition, the Avicanna Academy includes additional product information for patients, frequently asked questions, and a recording of Avicanna’s 3rd annual symposium which was hosted virtually in partnership with Shoppers on July 21, 2020. For more information visit https://www.avicanna.com/the-avicanna-academy/ .
The Company has also re-branded and re-launched its subsidiary, My Cannabis Clinic (formerly known as My Cannabis), which specializes in assisting patients to gain access to medical cannabis and cannabinoid-based products for medical use. My Cannabis Clinic is devoted to providing HCPs and patients with the support and education needed for medical cannabis use. My Cannabis Clinic believes in providing quality care to patients and providing education on the considerations and potential benefits that cannabis has to offer for medical use. Information about My Cannabis Clinic can be found at https://mycannabisclinic.org/ .
About Avicanna
Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.
Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including:
Pura H&W™: an advanced and clinically tested line of CBD consumer derma-cosmetic products; and,
RHO Phyto™: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nation-wide across Canada in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all developed with scientific rigour, manufactured under GMP standards and supported by pre-clinical data.
With ongoing clinical trials on its derma-cosmetic (Pura H&W), medical cannabis (RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the Company’s vision since its inception. Furthermore, Avicanna’s commitment to education is demonstrated through its annual medical symposium, the Avicanna Academy educational platform, and the My Cannabis Clinic patient program through its subsidiary company.
Avicanna manages its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. Through these sustainable, economical, and industrial scale subsidiaries, Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June 2020, Avicanna made history with a shipment of hemp seeds to the United States of America by completing the first ever export of hemp seeds from Colombia.
SOURCE Avicanna Inc.
Stay Connected
For more information about Avicanna, visit www.avicanna.com , call 1-647-243-5283, or contact Setu Purohit , President by email at [email protected] .
Cautionary Note Regarding Forward-Looking Information and Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and includes statements with respect to the ability of the RHO Phyto Rapid Act Sprays to be used in acute conditions where patients seek faster relief, the ability of the RHO Phyto Rapid Act Sprays to be used to supplement slower and longer acting products, the ability of the Company launching the RHO Phyto Deep Tissue Gel, Daily Cream and Simple Dose Capsules , the ability of My Cannabis Clinic to provide HCPs and patients with the support and education needed for medical cannabis use, and that there is a benefit to using cannabis for medical purposes. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.
Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated April 15, 2020 , filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com .
The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
Posted by AGORACOM-JC
at 9:19 AM on Monday, September 21st, 2020
Announced that it has received a third Purchase Order for COVID-19 screening solutions from Are You Afraid of the Dark Inc., a Canadian horror anthology television miniseries based in Vancouver, British Columbia.
The initial P.O. is for approximately $210,000 for a month, commencing on October 5, 2020
This production is scheduled to run for three (3) months, totalling $630,000.
Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits
Toronto, Ontario–(September 21, 2020) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that it has received a third Purchase Order (“P.O.”) for COVID-19 screening solutions from Are You Afraid of the Dark Inc., a Canadian horror anthology television miniseries based in Vancouver, British Columbia.
The miniseries is produced by Nickelodeon Productions and distributed by MTV Networks in the United States and YTV in Canada, a Corus Entertainment company. Nickelodeon, now in its 41st year, is the number one entertainment brand for kids. Nickelodeon and all related titles, characters and logos are trademarks of Viacom Inc.
The initial P.O. is for approximately $210,000 for a month, commencing on October 5, 2020. This production is scheduled to run for three (3) months, totalling $630,000. Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits.
As previously stated, Vancouver is the third-largest production centre in North America, worth CDN $3.2 Billion during 2018/19, according to Creative BC. British Columbia is home to several world-class Film and TV studios, including Bridge Studios, Mammoth Studios, Vancouver Film Studios, North Shore Studios, Ironwood Studios, Canadian Motion Picture Park, and The Crossing Studios.
Entire film and TV production in Canada represent $8.92 Billion in production volume, and full-time equivalent jobs represent 179,000 workers. In March 2020, the industry stopped worldwide, including in Vancouver, which represents 37% of Canadian Productions. The surrounding areas of Vancouver had 46 productions filming, which does not include the TV commercial market. Each of the shows potentially had a minimum of 100 people in their film crew.1
The next largest film and television market is Ontario, which represents 34% of Canadian productions. In 2019, Toronto’s film and television industry directly employed more than 28,000 people representing $3.17 Billion in production volume.
Additionally, with Canada having far fewer cases of COVID-19 than in the United States on a per capita basis according to data compiled by Johns Hopkins University, it demonstrates that Canada is a safer jurisdiction for filming and an advocate for the film industry, with our testing kits, collection services and labs already set up.
“With Vancouver productions quickly returning to the studios and filming, we feel that this is the tip of the iceberg for new film business for COVID-19 screening business,” said Marshall Gunter, CEO of the Company.
About Datametrex
Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.
For further information, please contact: Marshall Gunter – CEO Phone: (514) 295-2300 Email: [email protected]
Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Posted by AGORACOM-JC
at 9:11 AM on Monday, September 21st, 2020
Company has been successful in reaching many milestones across both product lines, Contact Tracing, and Contactless Marketing, with world-renowned brands, which have led to accelerating opportunities and contract negotiations with potential customers of similar stature
Loop announced an exciting successful launch with Telus, Canada’s leading telecom company
Contact Tracing continues to be a huge focus and gaining traction throughout North America in several verticals
The company has expanded its contactless services and continues to engage in many large-scale opportunities throughout North America
company is pleased to announce that it has been awarded $412,000 from its 2019 Scientific Research & Experimental Development application
VANCOUVER, BC, Sept. 21, 2020 – Loop Insights Inc. (TSXV: MTRX) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, automated marketing, and contact tracing to the brick and mortar space, is pleased to provide shareholders with the following corporate update reviewing recent significant business wins and near term expectations. The company has been successful in reaching many milestones across both product lines, Contact Tracing, and Contactless Marketing, with world-renowned brands, which have led to accelerating opportunities and contract negotiations with potential customers of similar stature.
BUSINESS DEVELOPMENT OPPORTUNITIES EXPANDING WITH EACH SUCCESSIVE WIN
Loop CEO Rob Anson stated “We have long known that our artificial intelligence driven technology stack could have a major impact on the real-world operations of enterprise-level customers, so it has been an incredible experience for Loop and its shareholders to begin seeing the third-party validation as we secure deals with great partners such as Telus, University of Houston and others. My message to shareholders is this is only the beginning, with Loop receiving significant inquiries, conducting online demonstrations and entering contract discussions on a daily basis. Moreover, we remain laser focused on maximizing our potential through Tier-1 channel resellers to help us grow even faster. As such, I can say with great confidence that Loop is extremely well-positioned to anticipate a very strong and successful run for the remainder of 2020.
TELUS PARTNERSHIP IS INDICATIVE OF A GLOBAL DISTRIBUTION STRATEGY WITH NATIONAL TELECOM PROVIDERS
On September 17th, Loop announced an exciting successful launch with Telus, Canada’s leading telecom company. This pilot program of our real-time, artificial intelligence-driven marketing platform launched in August and, upon successful completion, sees expansion into Telus 550+ corporate locations, as well as, their 2,000+ B2B reseller channel. This partnership is part of Loop’s global distribution strategy, in which the Company is already engaged in discussions with several similar telecom providers in the US, Australia, and other regions.
CONTACT TRACING ACCELERATES WITH INQUIRIES FROM GOVERNMENTS FOLLOWING PARTNERSHIP WITH NCAA DIV 1 UNIVERSITY OF HOUSTON
Contact Tracing continues to be a huge focus and gaining traction throughout North America in several verticals. The company has expanded its contactless services and continues to engage in many large-scale opportunities throughout North America. Areas of interest have come from, but not limited to, Provincial and Federal Government talks. Now that schools and sports teams are starting back up, contact tracing needs have never been as important. Securing University of Houston was a huge milestone and has now sparked interest throughout many other sports teams and schools across the US looking to restart and have a safe return of fans to their sporting facilities. Final negotiations are underway and the Company hopes to announce the next roll out in the near future.
LOOP RECEIVES $412,000 FROM FEDERAL GOVERNMENT SR&D RESEARCH AND DEVELOPMENT PROGRAM
The company is pleased to announce that it has been awarded $412,000 from its 2019 Scientific Research & Experimental Development (“SR&ED”) application. In order to qualify for this program, Loop had to demonstrate it “generated information that advances the understanding of scientific relations or technologies or advances a certain technology or overcomes a technological uncertainty.”
This additional injection of funds further strengthens the company’s strong cash position, which positions the Company well for future M&A opportunities.
LOOP OTCQB APPLICATION IN FINAL STAGES IN RESPONSE TO US INVESTOR DEMAN
Over the past months, the Company has received increasing inquiries from US-based investors who could not easily acquire shares in Loop. As a result, the company submitted applications to the necessary regulatory bodies and is hopeful for final approval as early as this week, making Loop shares available for trading on the OTCQB with full DTC eligibility.
LOOP PARTNERSHIP WITH LEADING POS VENDOR (VEND) YIELDS IMMEDIATE RESULTS WITH NEW CUSTOMERS
Another major milestone was the partnership with Vend, a global point of sale supplier with over 25,000 locations in over 142 companies. Upon successful completion of the integration with Vend, Loop has already signed several Vend retailers including Your CBD Store, the largest CBD brick and mortar retailer in the United States with over 650 locations.
The Company is now in discussions on a distribution strategy with Vend’s leadership team to become a global reseller of the Loop products which will help accelerate Loop’s potential adoption throughout Vends global network of retailers.
As next steps in leveraging the success with Vend, the Company has also begun an integration roll out with one of the largest e-commerce platforms. Point of sale partners continues to be a large focus as they are the Company’s quickest path to scale while allowing the Company to remain lean and agile.
About Loop Insights: Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia.
Forward-Looking Statements/Information:
This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.
SOURCE LOOP Insights Inc.
For further information: Loop Insights Inc., Rob Anson, CEO, T: +1 877-754-5336 Ext. 4, E: [email protected], LOOP Website: www.loopinsights.ai, Facebook: @LoopInsights, Twitter: @LoopInsights, LinkedIn: @LoopInsights
.png)
.png)
